Showing results (91-100 of 715) with videos related to
Sort By:
Pageof 72
Gut Microbes|March 4, 2026
Beyond bacilli: integrating the microbiome into the TB research agendaEdson Mambuque, Ana Del Amo-de Palacios, Samuel G Huete, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 20, 2015
Virome analysis of antiretroviral-treated HIV patients shows no correlation between T-cell activation and anelloviruses levelsLinlin Li, Xutao Deng, Antonio Charlys Da Costa, et al.AIDS (London, England)|August 18, 2009
HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyAndy I Choi, Michael G Shlipak, Peter W Hunt, et al.AIDS Research and Human Retroviruses|August 23, 2011
Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summarySusan F Plaeger, Brenda S Collins, Runa Musib, et al.Human Immunology|January 4, 2012
Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replicationRaymond N Deepe, Emily Kistner-Griffin, Jeffrey N Martin, et al.Antiviral Therapy|June 9, 2006
A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtideGeorge Beatty, Peter Hunt, Anna Smith, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 24, 2011
Incipient renal impairment as a predictor of subclinical atherosclerosis in HIV-infected patientsSergio Serrano-Villar, Vicente Estrada, Dulcenombre Gómez-Garre, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2022
Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort StudyJavier Martínez-Sanz, Sergio Serrano-Villar, Alfonso Muriel, et al.Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.Frontiers in Immunology|November 25, 2022
Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling studySergio Serrano-Villar, Calvin Cohen, Jason V Baker, et al.Pageof 72